Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of exacerbations and the prevention of relapses of mild to moderate ulcerative colitis.
Dosage form: granules, gastroresistant, prolonged-release
Active substance Dosage mesalazine 500 mg ATC: A07EC02
-
The drug is used for the treatment of exacerbations and the prevention of relapses of mild to moderate ulcerative colitis.
Dosage form: granules, gastroresistant, prolonged-release
Active substance Dosage mesalazine 1000 mg ATC: A07EC02
-
The drug is used for the treatment of exacerbations and the prevention of relapses in ulcerative colitis, as well as for the treatment of exacerbations of Crohn's disease.
Dosage form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 500 mg ATC: A07EC02